4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0001209191-22-024364
10% owner bought 424,464 shares at an average $4.08 ($1,731,068)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. 10% owner | 2022-04-11 | Purchase | +74,464 | $4.07 | $303,068 | 8,109,314 | I |
| Samsara BioCapital, L.P. 10% owner | 2022-04-12 | Purchase | +350,000 | $4.08 | $1,428,000 | 8,459,314 | I |
| Open-market purchases · 424,464 sh · avg $4.08 · $1,731,068 | |||||||
Loading xslF345X03/doc4.xml…